Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Closed-loop Automatic Control of the Inspiratory Fraction of Oxygen (FiO2-C) on Outcome of Extremely Preterm Infants - a Randomized Controlled Parallel Group Multicenter Trial for Safety and Efficacy

NCT03168516 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03168516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03168516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Closed-loop Automatic Control of the Inspiratory Fraction of Oxygen (FiO2-C) on Outcome of Extremely Preterm Infants - a Randomized Controlled Parallel Group Multicenter Trial for Safety and Efficacy
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 27, 2018
Completion date
December 31, 2026
Enrollment
1,065 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

infant,premature